{"article_id": "WST_q4_2020.txt", "article": ["west was named to the s&p 500 and recently joined the s&p 500 dividend aristocrats .", "we had approximately 20 % organic sales growth in the fourth quarter and 16 % for the full year driven again by robust biologics growth , high - value product sales and contract manufacturing .", "first up q4 , our financial results are summarized on slide 11 and the reconciliation of non-u.s. gaap measures are described in slides 20 to 23 .", "we recorded net sales of $ 580 million , representing organic sales growth of 19.8 % .", "covid - related net revenues are estimated to have been approximately $ 46 million in the quarter .", "proprietary product sales grew organically by 25.1 % in the quarter .", "high - value products , which made up more than 65 % of proprietary product sales in the quarter grew double digits and had solid momentum across all market units throughout q4 .", "we recorded a $ 211.1 million in gross profit , $ 57.9 million or 37.8 % above q4 of last year .", "and our gross profit margin of 36.4 % was a 390 - basis - point expansion from the same period last year .", "we saw improvements in adjusted operating profit with $ 119.1 million recorded this quarter compared to $ 73.1 million in the same period last year or a 62.9 % increase .", "our adjusted operating profit margin of 20.5 % was a 500 - basis - point increase from the same period last year .", "finally , adjusted diluted earnings per share grew 63 % for q4 .", "excluding stock tax benefit of $ 0.09 in q4 , earnings per share grew by approximately 55 % .", "volume and mix contributed $ 87.8 million or 18.7 percentage points of growth , including approximately $ 46 million of volume - driven by covid - 19 - related net demand .", "sales price increases contributed $ 5.5 million , a 1.2 percentage points of growth , and changes in foreign currency exchange rate increased sales by $ 16.3 million or an increase of 3.5 percentage points .", "slide 14 shows our consolidated gross profit margin of 36.4 % for q4 2020 , up from 32.5 % in q4 2019 .", "proprietary products fourth - quarter gross profit margin of 41.7 % was 370 basis points above the margin achieved in the fourth quarter of 2019 .", "contract manufacturing fourth - quarter gross profit margin of 17.2 % was 80 basis points above the margin achieved in the fourth quarter of 2019 .", "operating cash flow was $ 472.5 million for 2020 , an increase of $ 105.3 million compared to the same period last year , a 28.7 % increase .", "our 2020 capital spending was $ 174.4 million , $ 48 million higher than the same period last year and in line with guidance .", "working capital of $ 870.3 million at december 31 , 2020 , was $ 153.2 million higher than at december 31 , 2019 , primarily due to an increase in accounts receivable of $ 66 million due to increased sales activity and an increase in inventory of $ 85.6 million to position us to support the increasing needs of our customers .", "our cash balance at december 31 of $ 615.5 million , was $ 176.4 million more than our december 2019 balance , primarily due to our positive operating results .", "full year 2021 net sales guidance will be in a range of between $ 2.5 billion and $ 2.2 -- $ 2.525 billion .", "this includes estimated net covid incremental revenues of approximately $ 260 million .", "there is an estimated benefit of $ 75 million based on current foreign exchange rate .", "we expect organic sales growth to be approximately 13 % to 14 % .", "we expect our full year 2021 reported diluted earnings per share guidance to be in a range of $ 6 to $ 6.15 .", "accordingly , we have set capex guidance of $ 230 million to $ 240 million .", "estimated fx benefit on earnings per share has an impact of approximately $ 0.23 based on current foreign currency exchange rates and excludes future tax benefits from stock - based compensation ."], "summary_gold": "sees fy 2021 earnings per share $ 6.00 to $ 6.15 .<q>sees fy 2021 sales $ 2.5 billion to $ 2.525 billion .<q>full - year 2021 capital spending is expected to be in a range of $ 230 million to $ 240 million .<q>fy organic sales growth is expected to be in a range of 13 % to 14 % .", "summary_pred": "our 2020 capital spending was $ 174.4 million , $ 48 million higher than the same period last year and in line with guidance .<q>accordingly , we have set capex guidance of $ 230 million to $ 240 million .<q>our cash balance at december 31 of $ 615.5 million , was $ 176.4 million more than our december 2019 balance , primarily due to our positive operating results .<q>estimated fx benefit on earnings per share has an impact of approximately $ 0.23 based on current foreign currency exchange rates and excludes future tax benefits from stock - based compensation .<q>proprietary products fourth - quarter gross profit margin of 41.7 % was 370 basis points above the margin achieved in the fourth quarter of 2019 .<q>we expect organic sales growth to be approximately 13 % to 14 % .<q>full year 2021 net sales guidance will be in a range of between $ 2.5 billion and $ 2.2 -- $ 2.525 billion .<q>west was named to the s&p 500 and recently joined the s&p 500 dividend aristocrats .<q>covid - related net revenues are estimated to have been approximately $ 46 million in the quarter .<q>first up q4 , our financial results are summarized on slide 11 and the reconciliation of non-u.s. gaap measures are described in slides 20 to 23 .<q>we recorded a $ 211.1 million in gross profit , $ 57.9 million or 37.8 % above q4 of last year .", "len_article": 29, "len_summary_gold": 4, "len_summary_pred": 11, "len_sent_scores": 29}